文献速递青光眼

心血管药物与眼压:Gutenberg健康研究结果

Cardiovascular medication and intraocular pressure: results from the Gutenberg Health Study.
PubMed 文献 · Br J Ophthalmol · 2017-04-12

Gutenberg健康研究是一项基于人群的前瞻性观察性队列研究,纳入13527名受试者,分析心血管药物使用与眼压的关联。结果显示,在非青光眼受试者中,未发现任何一种心血管药物(尤其是全身性β受体阻滞剂)与眼压存在关联。

要点

  • 在非青光眼受试者中,全身性β受体阻滞剂使用与眼压无显著关联。
  • ACE抑制剂使用与眼压无关联(0.11 mm Hg;p=0.07)。
  • 作者认为全身性β受体阻滞剂对眼压降低的效果可忽略不计。

核心结论

  • 在非青光眼受试者中,未发现任何一种心血管药物(尤其是全身性β受体阻滞剂)与眼压存在关联。
  • 作者认为,局部和全身性β受体阻滞剂的长期漂移现象可能解释这一结果。
  • 作者的结果提示,全身性β受体阻滞剂对眼压降低的效果可忽略不计。

研究设计与样本

  • Gutenberg健康研究是一项在德国中西部开展的基于人群的前瞻性观察性队列研究。
  • 眼压使用非接触式眼压计测量。
  • 共纳入13527名受试者;排除眼压值缺失、使用局部降眼压药物或既往眼部手术者。
  • 药物使用与眼压的关联分析采用多变量线性回归(p<0.0038)。

主要发现

  • 选择性全身性β受体阻滞剂使用与眼压降低无统计学显著关联(-0.12 mm Hg,p=0.054)。
  • 非选择性全身性β受体阻滞剂使用与眼压降低无统计学显著关联(-0.70 mm Hg,p=0.037)。
  • 在调整体重指数、收缩压和中央角膜厚度后,ACE抑制剂使用与眼压无关联(0.11 mm Hg;p=0.07)。
  • 未发现任何一种心血管药物与眼压存在关联。

关键数值与推荐

  • 选择性全身性β受体阻滞剂与眼压:-0.12 mm Hg,p=0.054。
  • 非选择性全身性β受体阻滞剂与眼压:-0.70 mm Hg,p=0.037。
  • ACE抑制剂与眼压(调整体重指数、收缩压和中央角膜厚度后):0.11 mm Hg;p=0.07。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intraocular pressure (IOP) is well known to be associated with blood pressure and other cardiovascular risk factors. The influence of systemic cardiovascular, in particular antihypertensive, medication on IOP is still controversial. This study analyses the association between the use of cardiovascular medications and IOP in a large European cohort. METHODS: The Gutenberg Health Study is a population-based, prospective,observational cohort study in mid-western Germany. IOP was measured using a non-contact tonometer. The medication classes examined were peripheral vasodilators, diuretics, β-blockers (overall, selective and non-selective), calcium channel blockers, renin-angiotensin blockers (overall, ACE inhibitors and angiotensin-receptor blockers), nitrates, other antihypertensive medications, aspirin and statins. Subjects with missing IOP values, topical IOP-lowering medication or previous ocular surgery were excluded. In total, 13 527 subjects were enrolled in this study. Association analyses between medication use and IOP were performed using multivariable linear regression (p<0.0038). RESULTS: Neither selective nor non-selective systemic β-blocker intake was associated with statistically significant lower IOP (-0.12 mm Hg, p=0.054 and -0.70 mm Hg, p=0.037, respectively). IOP was not associated with the use of ACE inhibitors after adjustment for body mass index, systolic blood pressure and central corneal thickness (0.11 mm Hg; p=0.07). CONCLUSIONS: None of the cardiovascular medications, in particular systemic β-blocking agents, showed an association with IOP in non-glaucoma subjects. The long-term drift phenomenon of topical and systemic β-blocker might explain this result. Our results suggest that systemic β-blockers have a negligible effect on IOP reduction.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Höhn R, Mirshahi A, Nickels S, et al. Cardiovascular medication and intraocular pressure: results from the Gutenberg Health Study. Br J Ophthalmol. 2017. PMID: 28404666. doi:10.1136/bjophthalmol-2016-309993

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。